In vitro, this peptide conjugate retained strong B1R binding affinity and antagonistic potency (in the low nanomolar range), along with robust plasma stability, and significant uptake in PCa cells naturally expressing B1R. The gene discussed is BDKRB1; the disease is posterior cortical atrophy.